892505-90-7

Basic information

• Product Name: methyl 1-(4-bromobenzyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
• Synonyms: methyl 1-(4-bromobenzyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate
• CAS NO: 892505-90-7
• Molecular Weight: 389.249
• Mol File: 892505-90-7.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: methyl 1-(4-bromobenzyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 1-(4-bromobenzyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate(892505-90-7)
• EPA Substance Registry System: methyl 1-(4-bromobenzyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate(892505-90-7)

Safety Data

• Hazardous Substances Data: 892505-90-7(Hazardous Substances Data)

Upstream product

• 892505-89-4 3-amino-2-(4-bromo-benzylamino)-benzoic acid methyl ester 
• 254745-48-7 2-(4-bromo-benzylamino)-3-nitro-benzoic acid methyl ester 
• 150058-27-8 2-ethoxy-1H-benzimidazole-7-carboxylic acid methyl ester 
• 589-15-1 1-bromomethyl-4-bromobenzene 
• 78-09-1 orthocarbonic acid tetraethyl ester 

Downstream Products

• 854538-90-2 1-(4-bromobenzyl)-2-ethoxy-benzoimidazole-7-carboxylic acid 
• 1215298-35-3 methyl 2-ethoxy-1-({2′-[1-(phenylmethyl)-1H-tetrazol-5-yl][1,1′-biphenyl]-4-yl}methyl)-1H-benzimidazole-7-carboxylate 
• 948350-77-4 3-(4-{2-[(3,4-dimethyl-isoxazol-5-yl)-(2-trimethylsilanyl-ethoxymethyl)-sulfamoyl]-5-methyl-thiophen-3-yl}-benzyl)-2-ethoxy-3H-benzoimidazole-4-carboxylic acid methyl ester 

Relevant articles and documents

Convergent Synthesis of Angiotensin II Receptor Blockers through C-H Arylation of 1-Benzyl-5-phenyl-1 H -tetrazole with Functionalized Aryl Bromides

Highly convergent synthesis of angiotensin II receptor blockers has been accomplished by means of late-stage C-H arylation using functionalized aryl bromides. C-H arylation of 1-benzyl-5-phenyl-1 H -tetrazole with aryl bromides carrying methyl 2-ethoxyben

METHOD FOR PRODUCING N-PROTECTED SARTAN DERIVATIVE

PROBLEM TO BE SOLVED: To provide a method for efficiently producing intermediates of candesartan cilexetil and olmesartan. SOLUTION: The present invention provides a method for producing an N-protected sartan by causing an N-(4-bromobenzyl) imidazole deri

METHOD FOR OBTAINING BENZIMIDAZOLE DERIVATIVES AND INTERMEDIATES THEREOF

The present invention relates to a method for obtaining benzimizadole derivatives and intermediates thereof, preferably, for obtaining Candesartan and Candesartan cilexetil. Said method allows the benzimizadole derivatives to be obtained with a higher yield.